Suitability of superficial electron paramagnetic resonance dosimetry for in vivo measurement and verification of cumulative total doses during IMRT: A proof of principle

Zeitschrift für Medizinische Physik - Tập 31 - Trang 365-377 - 2021
Sebastian Höfel1,2, Michael K. Fix3, Malte Drescher1, Felix Zwicker2,4,5
1Department of Chemistry and Konstanz Research School Chemical Biology, University of Konstanz, Germany
2Klinik und Praxis fr Strahlentherapie am Klinikum Konstanz, Konstanz, Germany
3Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Switzerland
4Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
5Clinical Cooperation Unit Molecular Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Tài liệu tham khảo

International Atomic Energy Agency, 2016 Kry, 2017, AAPM TG 158: measurement and calculation of doses outside the treated volume from external-beam radiation therapy, Med Phys, 44, e391, 10.1002/mp.12462 World Health Organization, 2008 International Atomic Energy Agency, 2001 International Commission on Radiological Protection, 2000 International Atomic Energy Agency, 2013 Van Dam, 2006 Richtlinie 2013/59/Euratom vom 5. Dezember 2013 zur Festlegung grundlegender Sicherheitsnormen für den Schutz vor den Gefahren einer Exposition gegenüber ionisierender Strahlung und zur Aufhebung der Richtlinien 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom und 2003/122/Euratom, Amtsblatt der Europäischen Union L13/1 vom 17.01.2014. Gesetz zum Schutz vor der schädlichen Wirkung ionisierender Strahlung vom 27. Juni 2017 (BGBl. 2017 I S. 1966). Verordnung zum Schutz vor der schädlichen Wirkung ionisierender Strahlung vom 29. November 2018 (BGBl. 2018 I S. 2034, 2036). Baffa, 2014, Clinical applications of alanine/electron spin resonance dosimetry, Radiat Environ Biophys, 53, 233, 10.1007/s00411-013-0509-2 Indovina, 1989, In vivo ESR dosimetry in total body irradiation, Strahlenther Onkol, 165, 611 Kudynski, 1993, The application of EPR dosimetry for radiotherapy and radiation protection, Appl Radiat Isot, 44, 903, 10.1016/0969-8043(93)90042-9 Kuntz, 1996, Alanine-ESR in vivo dosimetry: a feasibility study and possible applications, Appl Radiat Isot, 47, 1183, 10.1016/S0969-8043(96)00171-6 Schaeken, 1996, One year of experience with alanine dosimetry in radiotherapy, Appl Radiat Isot, 47, 1177, 10.1016/S0969-8043(96)00040-1 Wagner, 2008, In vivo alanine/electron spin resonance (ESR) dosimetry in radiotherapy of prostate cancer: a feasibility study, Radiother Oncol, 88, 140, 10.1016/j.radonc.2008.03.017 Rech, 2014, In vivo dose evaluation during gynaecological radiotherapy using L-alanine/ESR dosimetry, Radiat Prot Dosimetry, 159, 194, 10.1093/rpd/ncu128 Wagner, 2017, Feasibility study of entrance and exit dose measurements at the contra lateral breast with alanine/electron spin resonance dosimetry in volumetric modulated radiotherapy of breast cancer, Phys Med Biol, 62, 5462, 10.1088/1361-6560/aa6ee2 Höfel, 2021, A practical EPR dosimetry system for routine use in radiotherapy: uncertainty analysis of lithium formate dosimeters at the therapeutic dose level, Phys Med Biol, 66, 045005, 10.1088/1361-6560/ab9414 Netherlands Commission on Radiation Dosimetry, 2017 Langen, 2010, QA for helical tomotherapy: report of the AAPM Task Group 148, Med Phys, 37, 4817, 10.1118/1.3462971 Agostinelli, 2003, Geant4 – a simulation toolkit, Nucl Instrum Methods Phys Res Sect A: Accel Spectrom Detect Assoc Equip, 506, 250, 10.1016/S0168-9002(03)01368-8 Sterpin, 2007, Monte Carlo simulation of the Tomotherapy treatment unit in the static mode using MC HAMMER, a Monte Carlo tool dedicated to Tomotherapy, J Phys: Conf Ser, 74, 021019 Sterpin, 2008, Monte Carlo simulation of helical tomotherapy with PENELOPE, Phys Med Biol, 53, 2161, 10.1088/0031-9155/53/8/011 BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP and OIML, Evaluation of Measurement Data—Guide to the Expression of Uncertainty in Measurement JCGM 100:2008. https://www.bipm.org/utils/common/documents/jcgm/JCGM_100_2008_E.pdf. Schneider, 2014, Accuracy of out-of-field dose calculation of tomotherapy and cyberknife treatment planning systems: a dosimetric study, Zeit Med Phys, 24, 211, 10.1016/j.zemedi.2013.10.008 Desrosiers, 2008, An absorbed-dose/dose-rate dependence for the alanine-EPR dosimetry system and its implications in high-dose ionizing radiation metrology, J Res Natl Inst Stand Technol, 113, 10.6028/jres.113.007 Gustafsson, 2008, Lithium formate EPR dosimetry for verifications of planned dose distributions prior to intensity-modulated radiation therapy, Phys Med Biol, 53, 4667, 10.1088/0031-9155/53/17/014 Waldeland, 2011, Review of the dose-to-water energy dependence of alanine and lithium formate EPR dosimeters and LiF TL-dosimeters – comparison with Monte Carlo simulations, Radiat Meas, 46, 945, 10.1016/j.radmeas.2011.03.014 Anton, 2013, Difference in the relative response of the alanine dosimeter to megavoltage X-ray and electron beams, Phys Med Biol, 58, 3259, 10.1088/0031-9155/58/10/3259 Ramsey, 2007, Helical tomotherapy superficial dose measurements, Med Phys, 34, 3286, 10.1118/1.2757000 Cheek, 2008, Accuracy of TomoTherapy treatments for superficial target volumes, Med Phys, 35, 3565, 10.1118/1.2952362 Avanzo, 2013, Dose to the skin in helical tomotherapy: results of in vivo measurements with radiochromic films, Phys Med, 29, 304, 10.1016/j.ejmp.2012.04.004 Accuray Inc., 2017 Accuray Inc., 2013 Kinhikar, 2008, Multileaf collimator transmission from the first Hi-Art II helical tomotherapy machine in India, J Cancer Res Ther, 4, 88, 10.4103/0973-1482.42255 Reynders, 2009, Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments, Radiother Oncol, 93, 71, 10.1016/j.radonc.2009.07.005 Anton, 2006, Uncertainties in alanine/ESR dosimetry at the Physikalisch-Technische Bundesanstalt, Phys Med Biol, 51, 5419, 10.1088/0031-9155/51/21/003 Wagner, 2011, Dose uncertainty in radiotherapy of patients with head and neck cancer measured by in vivo ESR/alanine dosimetry using a mouthpiece, Phys Med Biol, 56, 1373, 10.1088/0031-9155/56/5/010